- Is National Organization for Rare Disorders a tax-exempt 501(c)(3)?
- Yes. National Organization for Rare Disorders is recognised by the IRS as a 501(c)(3) organisation (EIN 13-3223946). The IRS recognised National Organization for Rare Disorders as tax-exempt in May 1989.
- What is National Organization for Rare Disorders's EIN?
- National Organization for Rare Disorders's Employer Identification Number (EIN) is 13-3223946. The EIN was assigned by the IRS in May 1989. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does National Organization for Rare Disorders do?
- NORD strives to improve the health and well-being of people with rare diseases by driving advances in care, research, and policy.
- Where is National Organization for Rare Disorders located?
- National Organization for Rare Disorders is located at 120 Longwater Drive 105, Norwell, MA, 02061.
- When was National Organization for Rare Disorders founded or recognised by the IRS?
- National Organization for Rare Disorders was recognised by the IRS as a tax-exempt organisation in May 1989. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is National Organization for Rare Disorders's annual revenue?
- On its most recent Form 990 (fiscal year 2025), National Organization for Rare Disorders reported $34.6M in total revenue and $40.4M in total expenses.
- Has National Organization for Rare Disorders been auto-revoked by the IRS?
- No. National Organization for Rare Disorders (EIN 13-3223946) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is National Organization for Rare Disorders listed in IRS Publication 78?
- Yes. National Organization for Rare Disorders is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.